Veterinary Vaccines Market - By Technology, By Application, By Disease Type- Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

Description

According to SPER Market Research, the Veterinary Vaccines global market is estimated to reach USD 14.58 billion by 2030 with a CAGR of 6.9%.

Veterinary vaccines are substances that are given to animals in order to increase the production of antibodies and give them immunity from one or more diseases. Branded veterinary vaccines include Inforce3®, which is given to healthy cattle, including pregnant cows, to help prevent respiratory diseases brought on by the infectious bovine rhinotracheitis (IBR) virus, parainfluenza 3 (PI3) virus, and the bovine respiratory syncytial virus (BRSV).

Growth over the historical era was driven by the expansion of new markets, rising expenditure on pets, rising illness prevalence, rising outbreaks of poultry diseases, and increasing zoonotic disease incidence. The lack of veterinarians, ignorance, high costs associated with animal care and storage, an increase in the supply of fake vaccinations, and strict laws all had a detrimental impact on growth during that time.

The market for veterinary vaccines is anticipated to see growth restrictions due to the concentration of clients and distributors. Recent years have seen a growth in the number of veterinarians working in big clinics and hospitals, as well as the consolidation of distributors of veterinary supplies and animal producers, notably of swine and poultry.

As a replacement for veterinary medicines to combat antibiotic resistance, nanotechnology is gaining ground in the market for veterinary vaccinations. Controlling matter at the atomic and molecular levels is the subject of nanotechnology research. The manufacture, stimulation of animal development, diagnosis, and treatment of veterinary vaccinations are all improved by the application of nanotechnology. In order to use less antibiotics and better identify harmful microorganisms, nanoparticles are mostly employed as substitute antimicrobial agents. In order to enhance the qualities and performance of new drugs and vaccine candidates as well as to lower animal organism drug resistance, they are also used as drug delivery agents..

Impact of COVID-19 on the Veterinary Vaccines Market

Demand for veterinary vaccination has increased significantly as a result of the recent COVID-19 epidemic. Veterinarian clinics all around the world have made substantial changes to ensure that livestock and animals receive the essential veterinary treatment and that new safety measures are in place to protect both animals and veterinarians.

Scope of the report:

Market size available for years: 2019-2030
Base year considered: 2021
Forecast period: 2022-2030

Segments covered: By Technology, By Application, By Disease Type , By Region

Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East, Africa

Companies Covered:

Animalcare, Agrovet Market Animal Health , BASF India Ltd., Bayer, Animal Health Cadila Vaccines Ltd., Bimeda, Boehringer Ingelheim GmbH, Ceva Sante Animale, Century Vaccines Limited,Chemo Argentina, DBK Pharma S.A.E., Elanco Animal Health Incorporated, HIPRA, IDT Biologika, Interfeed, Jurox Pty Ltd, Kyoritsu Seiyaku Corporation, Merck Animal Health, MSD Animal Health, Nimrod Veterinary Products Ltd., Novartis Animal Health, Phibro Animal Health Corporation, Sanofi Animal Health Inc., UCBVET, Virbac RSA, Zoetis India

Veterinary Vaccines Market, By Technology:

Based on the Technology, Veterinary Vaccines Market is segmented as; Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines , Recombinant Vaccines, Other Vaccines.

Veterinary Vaccines Market, By Application:

Based on the Application, Veterinary Vaccines Market is segmented as; Livestock Vaccines, Companion Animal Vaccines.

Veterinary Vaccines Market, By Disease Type:

Based on the Disease Type, Veterinary Vaccines Market is segmented as; Anaplasmosis, Canine Parvovirus, Foot & Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive & Respiratory Syndrome (PRRS), Others

Veterinary Vaccines Market, By Region:

The Veterinary Vaccines market is majorly driven by Asia Pacific. During the projected period, Asia Pacific is anticipated to have the quickest rate of growth in the worldwide Veterinary Vaccines market.

Product Code: PHAR2206

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1 Research data source
- 2.1.1 Secondary data
- 2.1.2 Primary data
- 2.1.3 SPER's internal database
- 2.1.4 Premium insight from KOL's
2.2 Market size estimation
- 2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1 Drivers
- 4.1.2 Restraints
- 4.1.3 Opportunities
- 4.1.4 Challenges
4.2. COVID-19 Impacts of the Veterinary Vaccines Market

5. Market variables and outlook

5.1. SWOT analysis
- 5.1.1 Strengths
- 5.1.2 Weaknesses
- 5.1.3 Opportunities
- 5.1.4 Threats
5.2. PESTEL analysis
- 5.2.1 Political landscape
- 5.2.2 Economic landscape
- 5.2.3 Social landscape
- 5.2.4 Technological landscape
- 5.2.5 Environmental landscape
- 5.2.6 Legal landscape
5.3. PORTER'S five forces analysis
- 5.3.1 Bargaining power of suppliers
- 5.3.2 Bargaining power of Buyers
- 5.3.3 Threat of Substitute
- 5.3.4 Threat of new entrant
- 5.3.5 Competitive rivalry
5.4. Heat map analysis

6. Veterinary Vaccines Market, By Technology, 2019-2030 (USD Million)

6.1. Live Attenuated Vaccines
6.2. Inactivated Vaccines
6.3. Toxoid Vaccines
6.4. Recombinant Vaccines
6.5. Other Vaccines

7. Veterinary Vaccines Market, By Application, 2019-2030 (USD Million)

7.1. Livestock Vaccines
7.2. Companion Animal Vaccines

8. Veterinary Vaccines Market, By Disease Type, 2019-2030 (USD Million)

8.1. Anaplasmosis
8.2. Canine Parvovirus
8.3. Foot & Mouth Disease
8.4. Newcastle Disease
8.5. Distemper Disease
8.6. Influenza
8.7. Porcine Reproductive & Respiratory Syndrome (PRRS)
8.8. Others

9. Veterinary Vaccines Market, By Region, 2019-2030 (USD Million)

9.1. North America
- 9.1.1. United States
- 9.1.2. Canada
- 9.1.3. Mexico
9.2. Europe
- 9.2.1. Germany
- 9.2.2. United Kingdom
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Rest of Europe
9.3. Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. India
- 9.3.4. Australia
- 9.3.5. South Korea
- 9.3.6. Rest of Asia-Pacific
9.4. South America
- 9.4.1. Brazil
- 9.4.2. Argentina
- 9.4.3. Rest of South America
9.5. Middle East & Africa
- 9.5.1. Kingdom of Saudi Arabia
- 9.5.2. United Arab Emirates
- 9.5.3. Rest of Middle East & Africa

10. Company Profiles

10.1. Animalcare
- 10.1.1. Company details
- 10.1.2. Financial outlook
- 10.1.3. Product summary
- 10.1.4. Recent developments
10.2. Agrovet Market Animal Health
- 10.2.1. Company details
- 10.2.2. Financial outlook
- 10.2.3. Product summary
- 10.2.4. Recent developments
10.3. BASF India Ltd.
- 10.3.1. Company details
- 10.3.2. Financial outlook
- 10.3.3. Product summary
- 10.3.4. Recent developments
10.4. Bayer Animal Health Cadila Vaccines Ltd.
- 10.4.1. Company details
- 10.4.2. Financial outlook
- 10.4.3. Product summary
- 10.4.4. Recent developments
10.5. Bimeda
- 10.5.1. Company details
- 10.5.2. Financial outlook
- 10.5.3. Product summary
- 10.5.4. Recent developments
10.6. Boehringer Ingelheim GmbH
- 10.6.1. Company details
- 10.6.2. Financial outlook
- 10.6.3. Product summary
- 10.6.4. Recent developments
10.7. Ceva Sante Animale
- 10.7.1. Company details
- 10.7.2. Financial outlook
- 10.7.3. Product summary
- 10.7.4. Recent developments
10.8. Century Vaccines Limited
- 10.8.1. Company details
- 10.8.2. Financial outlook
- 10.8.3. Product summary
- 10.8.4. Recent developments
10.9. Chemo Argentina
- 10.9.1. Company details
- 10.9.2. Financial outlook
- 10.9.3. Product summary
- 10.9.4. Recent developments
10.10. DBK Pharma S.A.E.
- 10.10.1. Company details
- 10.10.2. Financial outlook
- 10.10.3. Product summary
- 10.10.4. Recent developments
10.11. Elanco Animal Health Incorporated
- 10.11.1. Company details
- 10.11.2. Financial outlook
- 10.11.3. Product summary
- 10.11.4. Recent developments
10.12. HIPRA
- 10.12.1. Company details
- 10.12.2. Financial outlook
- 10.12.3. Product summary
- 10.12.4. Recent developments
10.13. IDT Biologika
- 10.13.1. Company details
- 10.13.2. Financial outlook
- 10.13.3. Product summary
- 10.13.4. Recent developments
10.14. Interfeed
- 10.14.1. Company details
- 10.14.2. Financial outlook
- 10.14.3. Product summary
- 10.14.4. Recent developments
10.15. Jurox Pty Ltd
- 10.15.1. Company details
- 10.15.2. Financial outlook
- 10.15.3. Product summary
- 10.15.4. Recent development
10.16. Kyoritsu Seiyaku Corporation
- 10.16.1. Company details
- 10.16.2. Financial outlook
- 10.16.3. Product summary
- 10.16.4. Recent developments
10.17. Merck Animal Health
- 10.17.1. Company details
- 10.17.2. Financial outlook
- 10.17.3. Product summary
- 10.17.4. Recent developments
10.18. MSD Animal Health
- 10.18.1. Company details
- 10.18.2. Financial outlook
- 10.18.3. Product summary
- 10.18.4. Recent developments
10.19. Nimrod Veterinary Products Ltd.
- 10.19.1. Company details
- 10.19.2. Financial outlook
- 10.19.3. Product summary
- 10.19.4. Recent developments
10.20. Novartis Animal Health
- 10.20.1. Company details
- 10.20.2. Financial outlook
- 10.20.3. Product summary
- 10.20.4. Recent developments
10.21. Phibro Animal Health Corporation
- 10.21.1. Company details
- 10.21.2. Financial outlook
- 10.21.3. Product summary
- 10.21.4. Recent developments
10.22. Sanofi Animal Health Inc.
- 10.22.1. Company details
- 10.22.2. Financial outlook
- 10.22.3. Product summary
- 10.22.4. Recent developments
10.23. UCBVET
- 10.23.1. Company details
- 10.23.2. Financial outlook
- 10.23.3. Product summary
- 10.23.4. Recent developments
10.24. Virbac RSA
- 10.24.1. Company details
- 10.24.2. Financial outlook
- 10.24.3. Product summary
- 10.24.4. Recent developments
10.25. Zoetis India
- 10.25.1. Company details
- 10.25.2. Financial outlook
- 10.25.3. Product summary
- 10.25.4. Recent developments